Steve Profit, general manager of Novo Nordisk Taiwan, shares a newcomers’ perspective as a recent transplant to the market from the company’s global office in Denmark. Profit goes on to share his mission to fulfil CEO Lars Fruergaard Jørgensen’s strategy of expanding beyond being a leader of diabetes at the global level, while also realizing his own commitment to bringing innovative products and new healthcare options to the patients of Taiwan.
The Novo Nordisk Taiwanese affiliate is rather like a high performing soccer team. I will help in giving clear direction, communication and tactics, and then results will come
